WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'5901 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 7'7071 Child (under 5 years) mortality rate: 292

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 16'914  16'582  16'252  15'924  15'596  11'651  9'264  7'283 
Births 422  419  417  414  412  413  362  320 
Surviving infants 412  410  407  404  401  396  340  291 
Pop. less than 5 years 2'040  2'023  1'994  1'976  1'954  1'895  1'580  1'346 
Pop. less than 15 years 5'928  5'913  5'889  5'871  5'844  5'095  4'248  3'367 
Female 15-49 years 4'519  4'401  4'286  4'167  4'052  2'784  2'074  1'593 

Number of reported cases

(Click for retrospective incidence data for Guatemala)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  8'802  2'703 
Mumps
ChartChart
  539  517 
Pertussis
ChartChart
  62  152  83  25  34  146  130  1'513 
Polio*
ChartChart
  287 
Rubella
ChartChart
  276 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  60 
Tetanus (total)**
ChartChart
  11  60  60 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guatemala)
Vaccine year result method % card seen                                                
BCG 2013  98  DHS   91  81  87  89  91  97  95  62  36 
DTP1 2013  98  DHS   91  88  96  99*  89  99*  94 
DTP3 2013  85  DHS   91  82  80  74  73  93  95  66  43 
DTP4          75  71  86  56 
IPV1          88  91 
HepB_BD          45  38  32  22  37 
HepB3 2013  85  DHS   91  82  80  74  73  93 
Hib3 2013  85  DHS   91  82  80  74  73  93 
JapEnc         
MCV1          86  86  99  67  93  86  68  23 
MCV2          81  65  59 
MenA         
PCV1          88  95  99*  78  88 
PCV2          84  87  85  60  58 
PCV3          84  81  82  51  24 
Pol3 2013  83  DHS   91  81  82  90  65  92  93  74  43 
Rota1          87  94  99  65  99* 
RotaC 2013  83  DHS   91  80  82  79  54  88 
RCV1          86  86  99  67  93 
TT2plus 2001  49  MCH   69  31  99*  99*  99*  22  27 
PAB         
VAD1          66  75  64  46  49 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guatemala)
BCG
ChartChart
  89  89  91  88  95  62  36 
DTP1
ChartChart
  99  99  89  97  94  86  68 
DTP3
ChartChart
  74  74  73  85  81  66  43 
HepB3
ChartChart
  74  74  73  85 
HepB_BD
ChartChart
  32  32  22  32 
Hib3
ChartChart
  74  74  73  85 
IPV1
 
MCV1
ChartChart
  77  77  67  85  86  68  23 
MCV2
ChartChart
 
PCV3
ChartChart
  82  82  51  24 
Pol3
ChartChart
  90  90  65  84  80  74  43 
RCV1
ChartChart
  77  77  67  85 
RotaC
ChartChart
  79  79  54  81 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 338  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 41
From 80 to 89% 24
From 50 to 79% 30
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG <12 months; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +1, +6 months; Yes at risk groups
HepB_Pediatric birth; Yes
HPV 10 years; +6 months; Yes From February 2018
Influenza_Adult Yes Elderly, adults of 65 years with chronic diseases, pregnant women, health care workers and risk groups
Influenza_Pediatric 6-35 months; Yes and children with chronic illness
IPV 2 months; Yes
MMR 12, 18 months; Yes
OPV 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 1st contact; +4 weeks; +6 months; +1, +1 year; Yes or 1st contact; +4 weeks; +6 months; +10, +10 years (if not at risk)
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  No  No  Yes  No 
What years does the MYP cover? number     2'015      2012-2016   
Nº of districts with microplans that include activities to raise immunization coverage number 338  338      334    335 

System performance

Total Nº districts in country number 338  338  338  334  334  334  335 
Nº districts with DTP3 coverage >=80% number 229  220  215  136  249  305  256 
% of districts with DTP3 coverage >=80% From 0 to 100% 68  65  64  41  75  91  76 
Nº districts with measles (MCV1) coverage >=95% number 130  132  233  47  141  130  71 
% of districts with MCV1 coverage >=95% From 0 to 100% 38  39  69  14  42  39  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  no  no  No  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  99  100  99  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.